Kristeleit, RS;
Miller, R;
Sellers, L;
Brown, N;
Devlin, M;
Woo, K;
Boyd, A;
... Linch, M; + view all
(2017)
A first-in-human Phase I/II, dose escalation, pharmacokinetic study to assess safety and tolerability of VAL201 in advanced prostate cancer.
Presented at: 15th International Congress on Targeted Anticancer Therapies (TAT 2017), Paris, France.
Preview |
Text
Kristeleit_A FIH trial of VAL-201.pdf Download (322kB) | Preview |
| Type: | Conference item (Presentation) |
|---|---|
| Title: | A first-in-human Phase I/II, dose escalation, pharmacokinetic study to assess safety and tolerability of VAL201 in advanced prostate cancer |
| Event: | 15th International Congress on Targeted Anticancer Therapies (TAT 2017) |
| Location: | Paris, France |
| Dates: | 06 - 08 March 2017 |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://www.eiseverywhere.com/ehome/192905/512982/ |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1553487 |
Archive Staff Only
 |
View Item |
